ClinicalTrials.gg
Not yet recruitingNCT07949617Updated Nov 19, 2026

Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months

An interventional study of Herreros bladder stimulation technique and Urinary catheterization in Urinary Tract Infection (UTI), sponsored by University of Castilla-La Mancha. Not yet recruiting. Open to participants aged 0 Days to 6 Months. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of Castilla-La Mancha · Not applicable, Interventional, and Diagnostic

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
0 Days to 6 Months
Sex
All
01

Study summary

Urinary tract infections are common in infants, but obtaining a reliable urine sample from babies younger than 6 months can be challenging. Bladder catheterization is a commonly used method for collecting urine, although it is an invasive procedure that may cause discomfort.

This randomized, controlled, open-label clinical trial will compare two methods of urine collection in infants younger than 6 months of age who are suspected of having a urinary tract infection and require a urine test. The study will be conducted at Toledo University Hospital in Spain.

Infants will be randomly assigned to one of two groups. The intervention group will undergo the Herreros technique, a non-invasive method that uses gentle tapping over the lower abdomen and circular massage of the lower back to stimulate spontaneous urination. The control group will undergo intermittent bladder catheterization to collect a urine sample.

The main objective is to compare the success of the two methods in obtaining a urine sample. Secondary objectives include comparing the time required to collect urine, sample contamination rates, pain or discomfort experienced by the infants, complications, costs, and parents' or legal guardians' satisfaction with the procedure.

The study aims to provide evidence on the effectiveness, safety, and cost-effectiveness of the Herreros technique compared with bladder catheterization in infants younger than 6 months.

Read the detailed description

Urinary tract infection (UTI) is a common bacterial infection in childhood. Obtaining reliable urine samples from infants who are not toilet-trained can be challenging. Bladder catheterization is an established method for urine collection, although it is invasive and may cause pain or discomfort. The Herreros urination stimulation technique is a non-invasive alternative based on physical stimulation of spontaneous urination.

This randomized, controlled, open-label clinical trial will be conducted at Toledo University Hospital, Castilla-La Mancha, Spain. The study will compare the Herreros urination stimulation technique with intermittent bladder catheterization for urine collection in infants with suspected UTI.

A minimum of 60 participants is planned, with 30 participants allocated to each study group. Sample size estimation was performed using the GRANMO program, considering expected urine collection success rates of 86% and 100% in the intervention and control groups, respectively, with a two-sided alpha level of 0.05 and statistical power greater than 80%.

Participants will be randomly assigned in a 1:1 ratio using a computer-generated randomization sequence managed by an independent unit coordinator. Due to the nature of the procedures, blinding of healthcare professionals performing the interventions will not be possible. However, laboratory personnel responsible for urine culture analysis and sample contamination assessment will be blinded to group allocation.

Intervention procedures

In the intervention group, urine collection will be attempted using the Herreros technique. The procedure involves feeding the infant approximately 20-30 minutes before the intervention, cleaning the genital area, and alternating gentle suprapubic tapping with circular massage of the lumbar paravertebral region using the thumbs. These maneuvers will be performed for a maximum of five minutes or until spontaneous urination occurs. A midstream urine sample will then be collected in a sterile container.

Non-pharmacological analgesia, including non-nutritive sucking or 2% sucrose solution, may be used in accordance with the study protocol. If urine collection is unsuccessful within five minutes, bladder catheterization will be performed to obtain the required sample, and this circumstance will be documented.

In the control group, urine samples will be obtained through intermittent bladder catheterization performed by qualified healthcare professionals in accordance with the hospital's standard clinical procedures. The time required to complete the procedure will be recorded using a stopwatch.

Data collection and statistical analysis

Study data will be recorded using a standardized data collection form. Statistical analyses will be performed using IBM SPSS Statistics. Categorical data will be expressed as frequencies and percentages, while quantitative data will be summarized using means and standard deviations or appropriate alternative descriptive statistics.

Between-group comparisons will be performed using the chi-square test or Fisher's exact test for categorical variables and Student's t-test or Mann-Whitney U test for quantitative variables, depending on data distribution. Pearson or Spearman correlation analyses and multiple logistic regression will be used, where appropriate, to explore associations between relevant study variables.

Safety monitoring and ethical considerations

Participants will be monitored by the healthcare professionals performing the urine collection procedures. Any complications or adverse events potentially related to either technique will be documented, and appropriate clinical care will be provided. Serious adverse events will be reported to the unit coordinator and principal investigator within 24 hours.

The study will commence only after approval by the relevant Research Ethics Committee and authorization from the participating hospital services. Written informed consent will be obtained from parents or legal guardians before participation. All study data will be handled confidentially in accordance with applicable Spanish data protection legislation and ethical principles governing biomedical research.

02

Conditions studied

  • Urinary Tract Infection (UTI)

Keywords

  • Urinary tract infection
  • Infant
  • Bladder stimulation
  • Herreros technique
  • Urinary catheterization
  • Urine collection
  • Randomized controlled trial
03

In context

Urinary Tract Infections

808 studies on the registry are indexed under Urinary Tract Infections; 133 are open to participants now.

This study's planned enrollment of 60 is below the median of 132 across 563 interventional studies indexed under Urinary Tract Infections.

Browse Urinary Tract Infections studies →

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 108 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants of both sexes under 6 months of age (up to 180 days).
  • Infants requiring a urine sample collection for the diagnosis of a suspected urinary tract infection (UTI) prescribed by a physician in the neonatology, pediatrics, or pediatric emergency department.
  • Parents or legal guardians willing and able to sign the form.

Exclusion criteria

Exclusion Criteria:

  • Infants with prior antibiotic treatment.
  • Infants with a diagnosis of urological or gynecological congenital malformations, severe phimosis, tight labial adhesions in females, genital infection, or complex genital abnormalities.
  • Infants presenting with any skin lesion (such as wounds, burns, trauma, etc.) that could contraindicate or prevent the performance of the Herreros technique and/or urinary catheterization.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Herreros Bladder Stimulation Group

    Infants undergo the non-invasive bladder stimulation technique described by Herreros et al., combining feeding with gentle suprapubic taps and lumbar paravertebral massage to induce spontaneous midstream urine collection.

    Procedure: Herreros bladder stimulation technique

  • Active comparator
    Urinary Catheterization Group

    Infants undergo intermittent urinary catheterization as the reference standard procedure for obtaining a sterile urine sample.

    Procedure: Urinary catheterization

Interventions

  • ProcedureHerreros bladder stimulation technique

    Infants receive the non-invasive bladder stimulation technique described by Herreros et al. This involves a feeding (breast milk or formula) 20 to 30 minutes prior to the procedure, followed by a maximum of 5 minutes of alternating cycles of gentle suprapubic tapping (using fingertips) and lumbar paravertebral massage (using circular thumb movements). Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is administered during the procedure.

    Also known as: Bladder stimulation technique Suprapubic tapping and lumbar massage technique

  • ProcedureUrinary catheterization

    Infants undergo intermittent urinary catheterization as the reference standard procedure. After proper perineal cleansing and the application of sterile lubricant, a pediatric urinary catheter (size 6-8 Fr) is gently inserted through the urethra into the bladder to obtain a sterile urine sample. Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is provided during the procedure.

    Also known as: Intermittent catheterization, Bladder catheterization

06

What researchers measure

Primary outcomes

  1. Successful urine sample collection rate

    Percentage of infants in each group in whom a sufficient urine sample for urinalysis and urocultivo is successfully obtained within 5 minutes after the start of the procedure.

    Time frame: Within 5 minutes (300 seconds) from the start of the procedure

Secondary outcomes

  1. Time to urine collection

    The total time elapsed (in seconds) from the start of the procedure until the successful collection of the urine sample.

    Time frame: From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).

  2. Urine sample contamination rate

    Percentage of collected urine samples classified as contaminated based on urocultive criteria (such as growth of two or more microorganisms, presence of non-uropathogens, or leukocyturia).

    Time frame: From urine collection until the final urine culture report, assessed up to 72 hours

  3. Parental satisfaction score

    Evaluation of parents' or legal guardians' satisfaction with the procedure, measured using an ad-hoc survey on a scale. PARENT/GUARDIAN OPINION AND SATISFACTION QUESTIONNAIRE FOR THE INFANT. The minimum score is 0, indicating the worst possible outcome, in which parents/legal guardians are not at all satisfied with the procedure performed on their infant or with the time required to obtain the urine sample. The maximum score is 10, indicating that parents/legal guardians are very satisfied with both the procedure performed and the time required to obtain the urine sample.

    Time frame: Immediately after the procedure, before discharge

  4. Procedure costs

    Direct economic cost of each procedure based on material resources utilized and healthcare personnel time required per successful sample obtained.

    Time frame: During the urine collection procedure (including rescue catheterization, if needed)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Herreros Fernandez ML, Gonzalez Merino N, Tagarro Garcia A, Perez Seoane B, de la Serna Martinez M, Contreras Abad MT, Garcia-Pose A. A new technique for fast and safe collection of urine in newborns. Arch Dis Child. 2013 Jan;98(1):27-9. doi: 10.1136/archdischild-2012-301872. Epub 2012 Nov 21. PubMed 23172785 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Jun 2027, 6 months later.

Of 136 non-industry interventional studies with no phase under Urinary Tract Infections, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 6 months is below that.

Counting every sponsor, half of 154 studies reached it within 22 months; a quarter within 8 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 19, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Jun 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07949617
Collaborators
Castilla-La Mancha Health Service
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

FRANCISCO JAVIER GÓMEZ MANZANO Principal Investigator, BSc
Contact
javier.gomezmanzano@uclm.es
+34653782821

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion